Stewards Investment Capital, BioVie, FreeCast and American Fusion Headline a Four-Region Broadcast Across the U.S., Latin America, MENA and Southeast Asia NEW YORK CITY , NY / ACCESS Newswire / October 24, 2026 / Where capital flows, how disease is treated, how entertainment reaches the screen and how the world is powered are all being rewritten at once. Tonight, New to The Street brings four companies working at each of those frontiers to a global business audience as Show #777 premieres at 6:30 p.m. ET on Bloomberg Television as sponsored programming, with distribution across the United States , Latin America , the Middle East and North Africa (MENA) and Southeast Asia . Hosted by Jane King and opening from the floor of the New York Stock Exchange, Show #777 features executive conversations with Bilal Adam , Chief Executive Officer of Stewards Investment Capital ; Cuong Do, President and Chief Executive Officer of BioVie Inc. (NASDAQ:BIVI); William "Bill" Mobley , Founder and Chief Executive Officer of FreeCast, Inc. (NASDAQ:CAST); and Brent Nelson , Executive Chairman of American Fusion Inc. (OTCQB:AMFN). "Show #777 is about builders who see what others miss," said Vince Caruso , Co-Founder and CEO of New to The Street. "An investment firm bridging developed and emerging markets. A biotech reporting what it believes is a first in long COVID. A software company turning connections into media businesses. And a fusion company that says it can simply sell power. These are the stories our audience in every region tunes in for. No politics. No current events. Only Opportunities To Consider™." Inside Show #777 Stewards Investment Capital CEO Bilal Adam Discusses Global Investing, Private Credit and Nasdaq Growth Bilal Adam , CEO of Stewards Investment Capital , joins Jane King to discuss the firm's international investment strategy, private credit solutions, and commitment to financial inclusion. With activities spanning South Africa , Mauritius , the United States , and Monaco , Stewards Investment Capital focuses on investment opportunities designed to deliver competitive risk-adjusted returns while supporting economic development. Adam discusses the firm's investment philosophy and its relationship with Nasdaq-listed Stewards Inc. (Nasdaq:SWRD), a U.S .-based diversified financial platform led by CEO and President Shaun Quin . He also highlights telecommunications infrastructure investments aimed at expanding connectivity and financial inclusion in underserved African communities. The conversation explores how Stewards Investment Capital provides institutional investors, pension funds, family offices, and high-net-worth individuals with access to private credit, portfolio diversification, and international investment opportunities. Adam also discusses Mauritius as an international financial hub, the growth of Stewards Inc.'s U.S . business, and the significance of the company's recent Nasdaq Opening Bell ceremony. Looking ahead, he shares his perspective on investment opportunities across developed and emerging markets and Stewards Investment Capital's long-term vision. Learn more at stewardsinvestment.com . BioVie Inc. (NASDAQ:BIVI): New Long COVID and Parkinson's Data Take Center Stage President and CEO Cuong Do reports that BioVie presented results from its ADDRESS-LC trial in long COVID and its SUNRISE-PD trial in Parkinson's disease at the American Neurological Association annual meeting, with the findings published in the peer-reviewed Annals of Neurology. Do says patients treated with investigational oral therapy bezisterim who entered the long COVID trial with a high symptom burden showed clinically relevant and statistically significant improvements in fatigue, malaise and cognitive impairment, or "brain fog." "This is the first trial that has ever shown to have any impact on long COVID neurological symptoms," Do said, noting that all 12 advisors who reviewed the results urged the company to move quickly to a confirmatory Phase 3 trial. Do says BioVie has been invited to present at the NIH's next RECOVER annual meeting and is seeking a meeting with the FDA on Phase 3 trial design. These findings require confirmation in a Phase 3 trial. Learn more at biovie.com . FreeCast, Inc. (NASDAQ:CAST): "The Connection Is Just the Beginning" Founder and CEO William Mobley explains why FreeCast is "not another streaming service." Instead, the company provides the software infrastructure that lets telecom companies, wireless carriers, internet providers, satellite companies and membership organizations launch their own branded entertainment hubs, offering free television, premium subscriptions, sports, advertising and commerce. "They bring the customers," Mobley said. "We bring the media and monetization technology." Mobley introduces PEAC, FreeCast's metric for "partner-enabled addressable customers," which measures potential distribution reach through enterprise agreements. He is clear that PEAC does not repres